rs779008975
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP3BS1_Supporting
The NM_014908.4(DOLK):c.323A>G(p.Glu108Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000293 in 1,605,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014908.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOLK | NM_014908.4 | c.323A>G | p.Glu108Gly | missense_variant | Exon 1 of 1 | ENST00000372586.4 | NP_055723.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151926Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245534Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 133154
GnomAD4 exome AF: 0.0000268 AC: 39AN: 1453334Hom.: 0 Cov.: 31 AF XY: 0.0000304 AC XY: 22AN XY: 722850
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151926Hom.: 0 Cov.: 31 AF XY: 0.0000944 AC XY: 7AN XY: 74186
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
The p.Glu108Gly variant in DOLK has not been previously reported in individuals with cardiomyopathy, but has been identified in 1/11556 Latino and 3/66278 Europ ean chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinst itute.org; dbSNP rs779008975). Computational prediction tools and conservation a nalysis suggest that the p.Glu108Gly variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, th e clinical significance of the p.Glu108Gly variant is uncertain. -
DK1-congenital disorder of glycosylation Uncertain:2
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 108 of the DOLK protein (p.Glu108Gly). This variant is present in population databases (rs779008975, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with DOLK-related conditions. ClinVar contains an entry for this variant (Variation ID: 505389). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DOLK protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Cardiovascular phenotype Uncertain:1
The p.E108G variant (also known as c.323A>G), located in coding exon 1 of the DOLK gene, results from an A to G substitution at nucleotide position 323. The glutamic acid at codon 108 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at